ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2830

Synovial Fluid T Cells of Patients with Reactive Arthritis  and Undifferentiated Spondyloarthropathy Respond to Salmonella Typhimurium Outer Membrane Protein a and  Induces IL17 and IL23 Production By  Synovial Fluid Mononuclear Cells

Ramnath Misra1, Smriti Chaurasia1, Ajit K Shashny2 and Amita Aggarwal3,4, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Central Institute of Medicinal and Aromatic Plants, Scientist, Lucknow, India, 3Clinical Immunology, Additional Professor Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Lucknow, India, 4Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: IL-23, reactive arthritis and synovial fluid, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We have previously shown that synovial fluid mononuclear cells (SFMCs) of patients with Reactive arthritis (ReA) and undifferentiated Spondyloarthropathy (uSpA) proliferated to low molecular weight fractions of outer membrane proteins (OMP) of S typhimurium. Proteomic analysis of the the stimulatory fractions predicted to consist of 10 proteins including OMPA and OMPD . In this study, we examined the in vitroimmunogenecity of recombinant (r ) OMP A and D by measuring frequency of antigen specific CD4+ and CD8+ T cells against rOMP A and D  in the synovial fluid (SF) of patients with ReA/uSpA. Further, induction of proinflammatory cytokines (IFN- γ, IL-17 and IL-23 ) were measured by SFMC stimulated by rOMPA and rOMP D in these patients. 

Methods: Patients presenting with typical  clincial picture of asymmetric lower limb oligoarthritis with a history of  preceding diarrhoea within 4 weeks were labelled as Rea and uSpA patients fulfilled ESSG criteria. Synovial fluid were aspirated from inflammed knee joint prior to steroid injections and monnonuclear cells (SFMC) were isolated and cultured with crude extract of s typhimurium OMP and rOMPA/D for flow cytometry, ELISPOT and cytokines in the culture supernatant.  Intracellular IFN-γ and IL17 producing  SF T (CD4+CD69+ and CD8+ CD69+) cells was enumerated  by Flow cytometry (Beckman Coulter, USA)  Antigen specific IFN-γ producing T cells were also measured  by ELISPOT. A positive response was taken if the ratio of  % cells or mean spots/well with antigen/Control ≥ 3.  IFN-γ (BD,USA) , IL17 and IL23 (ebioscinces, USA) levels were measured by commericial ELISA in the culture supernatant of antigen treated SFMCs.

Results: Out of 20 patients recruited, 17 were males with a median age 27.6 years (range 15-65 year). Eleven patients were ReA. The median duration of current episode was 15 days (range 3-180) days. HLA B27 were positive in 13/19 patients. Thirteen out of 20 patients with ReA/uSpA, showed a CD8+CD69+IFN+ response to crude OMP suggesting  triggered by S. typhimurium. Of these 13, 9 patient’s SF CD8+CD69+T cells positive for intracellular γ-IFN in response to rOMPA as compared to 4 patients who responded to  rOMPD. The mean frequency (%) of antigen specific CD8+CD69+ T cells were 0.56±0.5 to rOMPA and  0.24±0.15 to rOMPD in comparison to blank 0.18±0.17.  Regarding CD4+T cell response, 6 out of 15 were postive against crude OMP and of these 4 responded to rOMPA and only 2 responded to rOMPD. By ELISPOT assay  13, 7 and 3 patients showed increased IFN-γ producing T cells to crude OMP, rOMPA and rOMPD respectively. Only 1 RA patients SF CD8+T cells  showed response to crude OMP. SFMC upon stimulation with rOMP A and not  rOMP D produce significant IFN-γ, IL-17 and Il-23 in comparison to non treated cells (Table)

Table .  Induction of  pro inflammatory cytokines by SFMC stimulated by rOMP A /D

 

Cytokine

(pg/ml)

Blank,

 (a)

rOMP A

(b)

Significance

   b vs a

rOMP D

   c

Significance

  c vs a

IFN γ

691.98±999.27

3129.4±

5365.48

P<0.05

1793.2±

2842.79

No signifiance

IL17

36.42±

62.64

74.33±

129.27

P<0.05

41.58±

72.54

No

significance

IL23

44.86±

41.98

208.59±

269.56

P<0.05

49.87±

59.43

No

significance

Conclusion: OMPA is a major antigenic target in patients with Salmonella triggered ReA/uSpA.


Disclosure: R. Misra, None; S. Chaurasia, None; A. K. Shashny, None; A. Aggarwal, None.

To cite this abstract in AMA style:

Misra R, Chaurasia S, Shashny AK, Aggarwal A. Synovial Fluid T Cells of Patients with Reactive Arthritis  and Undifferentiated Spondyloarthropathy Respond to Salmonella Typhimurium Outer Membrane Protein a and  Induces IL17 and IL23 Production By  Synovial Fluid Mononuclear Cells [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/synovial-fluid-t-cells-of-patients-with-reactive-arthritis-and-undifferentiated-spondyloarthropathy-respond-to-salmonella-typhimurium-outer-membrane-protein-a-and-induces-il17-and-il23-pro/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-fluid-t-cells-of-patients-with-reactive-arthritis-and-undifferentiated-spondyloarthropathy-respond-to-salmonella-typhimurium-outer-membrane-protein-a-and-induces-il17-and-il23-pro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology